Epilepsia Open

Papers
(The H4-Index of Epilepsia Open is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Total posterior quadrant disconnection for drug‐resistant epilepsy in children72
Long‐term effectiveness and tolerability of ketogenic diet therapy in patients with genetic developmental and epileptic encephalopathy onset within the first 6 months of life70
Clinical characteristics and outcomes after new‐onset seizure among Zambian children with HIV during the antiretroviral therapy era66
Intestinal microbiome alterations in pediatric epilepsy: Implications for seizures and therapeutic approaches58
Commentary on “The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia”51
An interview with Ifrah Zawar, 2023 Epilepsia Open prize winner for clinical research48
Epilepsy following neonatal encephalopathy—Future directions40
Alterations of apparent diffusion coefficient from ultra high b‐values in the bilateral thalamus and striatum in MRI‐negative drug‐resistant epilepsy38
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges32
Patient complexity, depression, and quality of life in patients with epilepsy at an epilepsy center in Japan31
A companion to the preclinical common data elements for proteomics, lipidomics, and metabolomics data in rodent epilepsy models. A report of the TASK3‐WG4 omics working group of the ILAE/AES joint tra27
Key steps and barriers in the journey of patients with epilepsy through the National Healthcare System in Spain: The EPIPASS qualitative study26
Microglia and status epilepticus in the immature brain25
One‐year seizure freedom and quality of life in patients with drug‐resistant epilepsy receiving adjunctive vagus nerve stimulation in Japan25
Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy24
Longitudinal hippocampal diffusion‐weighted imaging and T2 relaxometry demonstrate regional abnormalities which are stable and predict subfield pathology in temporal lobe epilepsy23
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients22
Building a dashboard to inform policy and clinical practice using the Irish epilepsy electronic patient record: Towards a learning health system21
Risk of COVID‐19 infection and seizure exacerbation among patients with epilepsy during the peak of Omicron wave21
Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first‐line add‐on therapies for seizures in Dravet syndrome: A network meta‐analysis20
Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy20
Efficacy and Safety of adjunctive Perampanel in a prospective, real‐world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal‐onset Epilepsy: Study 50820
Characterization of low‐grade epilepsy‐associated tumor from implanted stereoelectroencephalography electrodes20
A companion to the preclinical common data elements and case report forms for neuropathology studies in epilepsy research. A report of the TASK3WG2 Neuropathology Working Group o20
0.120765209198